The Centre for Drug R&D (CDRD) and the Prevention for Organ Failure Centre (PROOF) have entered a preferred collaboration agreement to accelerate the knowledge translation of diagnoses and therapies. CDRD will contribute expertise in the development of target- and mechanism-based therapeutics, while PROOF offers expertise in biomarker identification and development, a repository of plausible drug targets and molecular signatures of physiological responses. Both organizations and Vancouver-based and funded in part through the Centres of Excellence for Commercialization and Research….